Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Conduit Pharmaceuticals I...

    NASDAQ: CDT · Real-Time Price · USD
    2.52
    0.03 (1.20%)
    At close: Jun 11, 2025, 3:59 PM
    2.56
    1.59%
    Pre-market: Jun 12, 2025, 08:00 AM EDT

    Conduit Pharmaceuticals Statistics

    Share Statistics

    Conduit Pharmaceuticals has 755.9K shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 755.9K

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 2.67%

    Owned by Institutions (%)

    n/a
    		 0.21%

    Shares Floating

    n/a
    		 344.73K

    Failed to Deliver (FTD) Shares

    n/a
    		 56,992

    FTD / Avg. Volume

    n/a
    		 17.14%

    Short Selling Information

    The latest short interest is 765.32K, so 95.97% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 765.32K

    Short % of Shares Out

    n/a
    		 95.97%

    Short % of Float

    n/a
    		 118.77%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is 21.1 and the forward PE ratio is null. Conduit Pharmaceuticals's PEG ratio is -0.01.

    PE Ratio

    n/a
    		 21.1

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 4.54

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -616.43

    P/FCF Ratio

    n/a
    		 -430.23

    PEG Ratio

    n/a
    		 -0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Conduit Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.25, with a Debt / Equity ratio of -1.1.

    Current Ratio

    n/a
    		 0.25

    Quick Ratio

    n/a
    		 0.25

    Debt / Equity

    n/a
    		 -1.1

    Debt / EBITDA

    n/a
    		 0.03

    Debt / FCF

    n/a
    		 -0.77

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $153,703,666.67

    Profits Per Employee

    n/a
    		 $33,072,166.67

    Employee Count

    n/a
    		 6

    Asset Turnover

    n/a
    		 219.94

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -29.53M

    Effective Tax Rate

    n/a
    		 -12.95%

    Stock Price Statistics

    The stock price has increased by -99.92% in the last 52 weeks. The beta is 2, so Conduit Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 2

    52-Week Price Change

    n/a
    		 -99.92%

    50-Day Moving Average

    n/a
    		 7.08

    200-Day Moving Average

    n/a
    		 87.03

    Relative Strength Index (RSI)

    n/a
    		 25.93

    Average Volume (20 Days)

    n/a
    		 332,568

    Income Statement

    In the last 12 months, Conduit Pharmaceuticals had revenue of 922.22M and earned 198.43M in profits. Earnings per share was 4.88.

    Revenue

    n/a
    		 922.22M

    Gross Profit

    n/a
    		 922.22M

    Operating Income

    n/a
    		 266.46M

    Net Income

    n/a
    		 198.43M

    EBITDA

    n/a
    		 266.46M

    EBIT

    n/a
    		 189.64M

    Earnings Per Share (EPS)

    n/a
    		 4.88
    Full Income Statement

    Balance Sheet

    The company has 554K in cash and 7.46M in debt, giving a net cash position of -6.9M.

    Cash & Cash Equivalents

    n/a
    		 554K

    Total Debt

    n/a
    		 7.46M

    Net Cash

    n/a
    		 -6.9M

    Retained Earnings

    n/a
    		 -29.1M

    Total Assets

    n/a
    		 3.21B

    Working Capital

    n/a
    		 544.29M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -9.68M and capital expenditures -51K, giving a free cash flow of -9.73M.

    Operating Cash Flow

    n/a
    		 -9.68M

    Capital Expenditures

    n/a
    		 -51K

    Free Cash Flow

    n/a
    		 -9.73M

    FCF Per Share

    n/a
    		 -0.24
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of 28.89% and 21.52%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 28.89%

    Pretax Margin

    n/a
    		 24.72%

    Profit Margin

    n/a
    		 21.52%

    EBITDA Margin

    n/a
    		 28.89%

    EBIT Margin

    n/a
    		 28.89%

    FCF Margin

    n/a
    		 -1.06%

    Dividends & Yields

    CDT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for CDT.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 20, 2025. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 May 20, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 1.45

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist